Hypoblast from human pluripotent stem cells regulates epiblast development

Recently, several studies using cultures of human embryos together with single-cell RNA-seq analyses have revealed differences between humans and mice, necessitating the study of human embryos1–8. Despite the importance of human embryology, ethical and legal restrictions have limited post-implantation-stage studies. Thus, recent efforts have focused on developing in vitro self-organizing models using human stem cells9–17. Here, we report genetic and non-genetic approaches to generate authentic hypoblast cells (naive hPSC-derived hypoblast-like cells (nHyCs))—known to give rise to one of the two extraembryonic tissues essential for embryonic development—from naive human pluripotent stem cells (hPSCs). Our nHyCs spontaneously assemble with naive hPSCs to form a three-dimensional bilaminar structure (bilaminoids) with a pro-amniotic-like cavity. In the presence of additional naive hPSC-derived analogues of the second extraembryonic tissue, the trophectoderm, the efficiency of bilaminoid formation increases from 20% to 40%, and the epiblast within the bilaminoids continues to develop in response to trophectoderm-secreted IL-6. Furthermore, we show that bilaminoids robustly recapitulate the patterning of the anterior–posterior axis and the formation of cells reflecting the pregastrula stage, the emergence of which can be shaped by genetically manipulating the DKK1/OTX2 hypoblast-like domain. We have therefore successfully modelled and identified the mechanisms by which the two extraembryonic tissues efficiently guide the stage-specific growth and progression of the epiblast as it establishes the post-implantation landmarks of human embryogenesis.


Field-specific reporting
Please select the one below that is the best fit for your research.If you are not sure, read the appropriate sections before making your selection.

Life sciences
Behavioural & social sciences Ecological, evolutionary & environmental sciences For a reference copy of the document with all sections, see nature.com/documents/nr-reporting-summary-flat.pdf

Life sciences study design
All studies must disclose on these points even when the disclosure is negative.

Sample size
No statistical methods were used to predetermine sample size.Sample sizes were determined based on similar studies performed on stem cell-based model (ex. Zheng et al, Nature, 2019;Moris et al, Nature, 2021;Kagawa et at Nature 2022) Data exclusions No data were excluded.

Replication
All experiments were conducted with at least two biologically independent experiments.Exact number of experiments and samples are indicated in figures, figure legends and the section of Statistic and Reproducibility in the Methods.
Randomization Samples were allocated based on the corresponding test conditions.

Blinding
Investigators were not blinded to group allocation during data collection and analysis, as these were nonsubjective.

Behavioural & social sciences study design
All studies must disclose on these points even when the disclosure is negative.

Study description
Briefly describe the study type including whether data are quantitative, qualitative, or mixed-methods (e.g.qualitative cross-sectional, quantitative experimental, mixed-methods case study).

Research sample
State the research sample (e.g.Harvard university undergraduates, villagers in rural India) and provide relevant demographic information (e.g.age, sex) and indicate whether the sample is representative.Provide a rationale for the study sample chosen.For studies involving existing datasets, please describe the dataset and source.

Sampling strategy
Describe the sampling procedure (e.g. random, snowball, stratified, convenience).Describe the statistical methods that were used to predetermine sample size OR if no sample-size calculation was performed, describe how sample sizes were chosen and provide a rationale for why these sample sizes are sufficient.For qualitative data, please indicate whether data saturation was considered, and what criteria were used to decide that no further sampling was needed.

Data collection
Provide details about the data collection procedure, including the instruments or devices used to record the data (e.g.pen and paper, computer, eye tracker, video or audio equipment) whether anyone was present besides the participant(s) and the researcher, and whether the researcher was blind to experimental condition and/or the study hypothesis during data collection.

Timing
Indicate the start and stop dates of data collection.If there is a gap between collection periods, state the dates for each sample cohort.

Data exclusions
If no data were excluded from the analyses, state so OR if data were excluded, provide the exact number of exclusions and the rationale behind them, indicating whether exclusion criteria were pre-established.

Non-participation
State how many participants dropped out/declined participation and the reason(s) given OR provide response rate OR state that no participants dropped out/declined participation.

Randomization
If participants were not allocated into experimental groups, state so OR describe how participants were allocated to groups, and if allocation was not random, describe how covariates were controlled.

nature research | reporting summary
April 2020 Ecological, evolutionary & environmental sciences study design All studies must disclose on these points even when the disclosure is negative.

Study description
Briefly describe the study.For quantitative data include treatment factors and interactions, design structure (e.g.factorial, nested, hierarchical), nature and number of experimental units and replicates.

Sampling strategy
Note the sampling procedure.Describe the statistical methods that were used to predetermine sample size OR if no sample-size calculation was performed, describe how sample sizes were chosen and provide a rationale for why these sample sizes are sufficient.

Data collection
Describe the data collection procedure, including who recorded the data and how.
Timing and spatial scale Indicate the start and stop dates of data collection, noting the frequency and periodicity of sampling and providing a rationale for these choices.If there is a gap between collection periods, state the dates for each sample cohort.Specify the spatial scale from which the data are taken

Data exclusions
If no data were excluded from the analyses, state so OR if data were excluded, describe the exclusions and the rationale behind them, indicating whether exclusion criteria were pre-established.

Reproducibility
Describe the measures taken to verify the reproducibility of experimental findings.For each experiment, note whether any attempts to repeat the experiment failed OR state that all attempts to repeat the experiment were successful.

Randomization
Describe how samples/organisms/participants were allocated into groups.If allocation was not random, describe how covariates were controlled.If this is not relevant to your study, explain why.

Blinding
Describe the extent of blinding used during data acquisition and analysis.If blinding was not possible, describe why OR explain why blinding was not relevant to your study.

Did the study involve field work?
Yes No

Field conditions
Describe the study conditions for field work, providing relevant parameters (e.g.temperature, rainfall).

Location
State the location of the sampling or experiment, providing relevant parameters (e.g.latitude and longitude, elevation, water depth).
Access & import/export Describe the efforts you have made to access habitats and to collect and import/export your samples in a responsible manner and in compliance with local, national and international laws, noting any permits that were obtained (give the name of the issuing authority, the date of issue, and any identifying information).

Disturbance
Describe any disturbance caused by the study and how it was minimized.
Reporting for specific materials, systems and methods We require information from authors about some types of materials, experimental systems and methods used in many studies.Here, indicate whether each material, system or method listed is relevant to your study.

Sequencing depth
Describe the sequencing depth for each experiment, providing the total number of reads, uniquely mapped reads, length of reads and whether they were paired-or single-end.

Antibodies
Describe the antibodies used for the ChIP-seq experiments; as applicable, provide supplier name, catalog number, clone name, and lot number.
Peak calling parameters Specify the command line program and parameters used for read mapping and peak calling, including the ChIP, control and index files used.
Describe the research sample (e.g. a group of tagged Passer domesticus, all Stenocereus thurberi within Organ Pipe Cactus National Monument), and provide a rationale for the sample choice.When relevant, describe the organism taxa, source, sex, age range and any manipulations.State what population the sample is meant to represent when applicable.For studies involving existing datasets, describe the data and its source.
If you are not sure if a list item applies to your research, read the appropriate section before selecting a response.Describe how participants were recruited.Outline any potential self-selection bias or other biases that may be present and how these are likely to impact results.Describe the experimental replicates, specifying number, type and replicate agreement.